Octant
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules. Combining advanced cell engineering, high-throughput chemistry, and automation we are engineering best-in-class drugs across rare disease, oncology, and immunology.
Work at Octant in HR or recruiting? Claim this page
Headcount trend
Octant went from 60 employees in Apr 2023 to 71 in Mar 2025. Oct 2024 to Mar 2025: 2 people joined, 2 left.
Headcount data through Mar 2025
Org structure
Headcount by department
Hiring now
See all jobsH-1B sponsorship
Funding
- Apr 2022 · Series B · $80M · Catalio Capital Management, Andreessen Horowitz Bio Fund, Allen & Co
- May 2020 · Series A · $30M · Andreessen Horowitz, 8VC, SV Angel
Peer reviews
Worked with someone at Octant?
Anonymous peer reviews on OffTheRecord
Similar companies
Octant FAQ
How many employees does Octant have?
Octant has about 71 employees, unchanged over the 3 months to Mar 2025.
Does Octant sponsor H1B visas?
Yes. Octant filed 6 H1B (LCA) applications in FY2024, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Octant's revenue per employee?
Octant makes about $56K in revenue per employee, based on $4M annual revenue and 71 employees.
How much funding has Octant raised?
Octant has raised $110M in total funding; its latest round was Series B in Apr 2022.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.